- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07507877
Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness
April 13, 2026 updated by: Ibrahim Mamdouh Esmat, Ain Shams University
Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness in Spontaneously Breathing Patients in Sepsis-related Acute Circulatory Failure: a Prospective Observational Study
Fluid responsiveness refers to the ability of the left ventricle to significantly increase stroke volume following fluid administration, and its assessment is critical in managing acute circulatory failure while avoiding fluid overload.Infraclavicular axillary vein collapsibility index is a substitute for inferior vena cava collapsibility index in assessment for the need of fluid resuscitation in spontaneously breathing sepsis related acute circulatory failure patients.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ibrahim Mamdouh Esmat
- Phone Number: 01001241928
- Email: ibrahim_mamdouh@med.asu.edu.eg
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Ain-Shams University Hospitals
-
Contact:
- Ibrahim Mamdouh Esmat
- Phone Number: 01001241928
- Email: ibrahim_mamdouh@med.asu.edu.eg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
- Patients with sepsis must meet at least two or more criteria of systemic inflammatory response syndrome (SIRS).
- Spontaneously breathing patients.
- Clinical signs of acute circulatory failure.
Description
Inclusion Criteria:
- Adult patients ≥18 years.
- Patients with sepsis must meet at least two or more criteria of systemic inflammatory response syndrome (SIRS).
- Spontaneously breathing patients.
- Clinical signs of acute circulatory failure.
Exclusion Criteria:
- Patients below the age of 18 years.
- Mechanically ventilated patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The infraclavicular axillary vein collapsibility index changes in response to fluid challenge.
Time Frame: Fluid challenge over 10 min time period.
|
The infraclavicular axillary vein collapsibility index changes in response to fluid challenge.
A collapsibility index greater than fifty percent in spontaneously breathing patients is commonly associated with a right atrial pressure between zero and five millimeters of mercury.
|
Fluid challenge over 10 min time period.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 4, 2026
Primary Completion (Estimated)
November 4, 2026
Study Completion (Estimated)
November 4, 2026
Study Registration Dates
First Submitted
March 27, 2026
First Submitted That Met QC Criteria
March 27, 2026
First Posted (Actual)
April 2, 2026
Study Record Updates
Last Update Posted (Actual)
April 15, 2026
Last Update Submitted That Met QC Criteria
April 13, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMASU-MS 257 / 2026
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RecruitingSepsis | Sepsis, Severe | Sepsis and Septic Shock | Sepsis at Intensive Care Unit | Sepsis, Septic Shock | Sepsis, Severe Sepsis and Septic Shock | Sepsis With Multiple Organ Dysfunction (MOD) | Sepsis With Acute Organ DysfunctionUnited States
-
Assiut UniversityNot yet recruitingSepsis Induced Myocardial Dysfunction | Sepsis Induced CardiomyopathyEgypt
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
Clinical Trials on Infraclavicular axillary vein collapsibility index
-
Gaziosmanpasa Research and Education HospitalCompletedShock | Cesarean Section Complications | Regional Anesthesia Morbidity | Hemodynamic InstabilityTurkey (Türkiye)
-
Ankara City Hospital BilkentNot yet recruitingCesarean Section | Preeclampsia | Spinal Anesthesia-Induced HypotensionTurkey (Türkiye)
-
University of GaziantepNot yet recruitingAnesthesia, General | Hypotension | Cholecystectomy, LaparoscopicTurkey (Türkiye)
-
Ain Shams UniversityRecruitingGeneral Anesthesia | Craniotomy | Induction | Inferior Vena Cava | Collapsibility Index | Caval Aorta IndexEgypt
-
Zagazig UniversityEnrolling by invitationAchievement of High-quality Analgesia in Elbow SurgeriesEgypt
-
Alexandria UniversityCompletedInfraclavicular Vein Cannulation | Venous CannulationEgypt
-
Tanta UniversityEnrolling by invitationProstate | Lung Ultrasound Score | Transurethral Resection (TUR) SyndromeEgypt
-
Isfahan University of Medical SciencesCompletedHemorrhagic Shock | IVC Collapsibility IndexIran, Islamic Republic of
-
Rajiv Gandhi Cancer Institute & Research Center...Completed